227 related articles for article (PubMed ID: 16307531)
1. Non-insulin dependent diabetes mellitus: present therapies and new drug targets.
Das SK; Chakrabarti R
Mini Rev Med Chem; 2005 Nov; 5(11):1019-34. PubMed ID: 16307531
[TBL] [Abstract][Full Text] [Related]
2. Prospects for kinase activity modulators in the treatment of diabetes and diabetic complications.
Bullock WH; Magnuson SR; Choi S; Gunn DE; Rudolph J
Curr Top Med Chem; 2002 Sep; 2(9):915-38. PubMed ID: 12171564
[TBL] [Abstract][Full Text] [Related]
3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
4. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
Wolffenbuttel BH; van Haeften TW
Drugs; 1995 Aug; 50(2):263-88. PubMed ID: 8521759
[TBL] [Abstract][Full Text] [Related]
5. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
6. Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus.
Bajaj M; Suraamornkul S; Hardies LJ; Glass L; Musi N; DeFronzo RA
Diabetologia; 2007 Aug; 50(8):1723-31. PubMed ID: 17520238
[TBL] [Abstract][Full Text] [Related]
7. New drug targets for type 2 diabetes and the metabolic syndrome.
Moller DE
Nature; 2001 Dec; 414(6865):821-7. PubMed ID: 11742415
[TBL] [Abstract][Full Text] [Related]
8. [The current aspects of the pharmacological correction of hyperglycemia in patients with non-insulin-dependent diabetes mellitus (type 2)].
Gorbenko NI
Eksp Klin Farmakol; 1999; 62(5):71-8. PubMed ID: 10572759
[TBL] [Abstract][Full Text] [Related]
9. The Hot and Potential Targets of Type 2 Diabetes Mellitus Treatment in Recent Decade.
Xu Q; Wang L; Luo J; Shi D
Curr Drug Targets; 2018; 19(1):55-69. PubMed ID: 28270085
[TBL] [Abstract][Full Text] [Related]
10. Past and current perspective on new therapeutic targets for Type-II diabetes.
Patil PD; Mahajan UB; Patil KR; Chaudhari S; Patil CR; Agrawal YO; Ojha S; Goyal SN
Drug Des Devel Ther; 2017; 11():1567-1583. PubMed ID: 28579755
[TBL] [Abstract][Full Text] [Related]
11. Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes.
Toyoshima Y; Gavrilova O; Yakar S; Jou W; Pack S; Asghar Z; Wheeler MB; LeRoith D
Endocrinology; 2005 Sep; 146(9):4024-35. PubMed ID: 15947005
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for the treatment of patients with type 2 diabetes mellitus: rationale and specific agents.
Cefalu WT
Clin Pharmacol Ther; 2007 May; 81(5):636-49. PubMed ID: 17438539
[TBL] [Abstract][Full Text] [Related]
13. The role of blood glucose-lowering drugs in the light of the UKPDS. United Kingdom Prospective Diabetes Study.
Monnier L
Diabetes Obes Metab; 1999 Sep; 1 Suppl 2():S14-23. PubMed ID: 11221798
[No Abstract] [Full Text] [Related]
14. Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes.
Musi N; Goodyear LJ
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):119-27. PubMed ID: 12476786
[TBL] [Abstract][Full Text] [Related]
15. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
16. Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.
Luna V; Casauban L; Sajan MP; Gomez-Daspet J; Powe JL; Miura A; Rivas J; Standaert ML; Farese RV
Diabetologia; 2006 Feb; 49(2):375-82. PubMed ID: 16395615
[TBL] [Abstract][Full Text] [Related]
17. [Type 2 diabetes: what therapeutic strategy?].
Grimaldi A; Hartemann-Heurtier A
Presse Med; 2001 Feb; 30(6):288-97. PubMed ID: 11252980
[TBL] [Abstract][Full Text] [Related]
18. Non-insulin-dependent diabetes mellitus: a clinical strategy.
Skyler JS
Diabetes Care; 1984; 7 Suppl 1():118-29. PubMed ID: 6376024
[TBL] [Abstract][Full Text] [Related]
19. [Hypoglycemic therapy in heart disease patients with type 2 diabetes mellitus].
Cosmi F; Cosmi D
G Ital Cardiol (Rome); 2010 Jun; 11(6):460-6. PubMed ID: 20922871
[TBL] [Abstract][Full Text] [Related]
20. Long-term AICAR administration and exercise prevents diabetes in ZDF rats.
Pold R; Jensen LS; Jessen N; Buhl ES; Schmitz O; Flyvbjerg A; Fujii N; Goodyear LJ; Gotfredsen CF; Brand CL; Lund S
Diabetes; 2005 Apr; 54(4):928-34. PubMed ID: 15793229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
